Work

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.

Year: 2001

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: F Bracho, M D Krailo, V Shen, S Bergeron, V Davenport, W Liu-Mares, B R Blazar, A Panoskaltsis-Mortari, C van de Ven, R Secola, M M Ames, J M Reid, G H Reaman, M S Cairo

Institutions: Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Southern California, University of California, Irvine, Columbia University, University of Minnesota, Mayo Clinic, Children's National

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Mayo Cancer Genetic Epidemiology Training Program

OpenAlex ID: W2108949223

FWCI: 0.883

Cites: 35

Cited by: 17

Related to: 10